Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives

This study has been completed.
Sponsor:
Information provided by:
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT00539487
First received: September 25, 2007
Last updated: November 7, 2013
Last verified: November 2013

September 25, 2007
November 7, 2013
January 2007
November 2007   (final data collection date for primary outcome measure)
Blood pressure reduction [ Time Frame: 4 month ]
Not Provided
Complete list of historical versions of study NCT00539487 on ClinicalTrials.gov Archive Site
Change in metabolic parameters Safety [ Time Frame: n.a. ]
Not Provided
Not Provided
Not Provided
 
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives
TOP -Study Telmisartan - Therapy of Hypertension and Life-style Changes in Cardiovascular Risk Patients

This observational non-interventional study will assess (under conditions of clinical practice in daily routine) the antihypertensive efficacy of telmisartan treatment with or without active promotion of lifestyle changes in hypertensive patients at high cardiovascular risk

Study Design:

Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

hypertensive patients

  • Hypertension
  • Obesity
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
5827
Not Provided
November 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

patients with essential hypertension aged >/= 18 years with one of the following risk factors: history of coronary artery disease or stroke/TIA or peripheral artery disease or diabetes mellitus.

Exclusion Criteria:

according to SPC

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00539487
502.523, n.a.
Not Provided
Boehringer Ingelheim, Study Chair, Boehringer Ingelheim
Boehringer Ingelheim
Not Provided
Study Chair: Boehringer Ingelheim Boehringer Ingelheim
Boehringer Ingelheim
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP